Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hau

Showing results (11-20 of 180) with videos related to

Pageof 18
Sort By:
Expert Review of Neurotherapeutics|October 9, 2009
Advances in the therapy of high-grade glioma at relapse: pegylated liposomal doxorubicinPeter Hau, Joerg Dietrich, Klaus Fabel, et al.
Clinical Neuroradiology|June 24, 2016
The Neuroradiological Spectra of Adult and Pediatric Medulloblastoma Differ : Results from a Literature-based Meta-analysisDagmar Beier, Selin Kocakaya, Peter Hau, et al.
International Journal of Cancer|November 15, 2018
Reply to Lu: Connecting the dots between metformin and high-grade gliomaCorinna Seliger, Michael Gerken, Michael F Leitzmann, et al.
Acta Neuropathologica|May 22, 2013
Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approachMarkus J Riemenschneider, David N Louis, Michael Weller, et al.
Neurological Research and Practice|April 3, 2026
Preventive strategies against brain metastases: current state of the art and future directionsFranziska Maria Ippen, Franz Felix Konen, Peter Hau, et al.
Neuro-Oncology|December 29, 2014
Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patientsMarkus Hutterer, Elke Hattingen, Christoph Palm, et al.
Journal of Religion and Health|November 5, 2024
Spirituality in Professional Patient-Centered Care for Adults with Primary Brain Tumors: An Exploratory Scoping ReviewReinhard Grabenweger, Daniela Völz, Christiane Weck, et al.
Anticancer Research|May 17, 2002
Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal originPeter Hau, Rainer Apfel, Petra Wiese, et al.
International Journal of Molecular Sciences|March 18, 2020
Tumor Cell Invasion in GlioblastomaArabel Vollmann-Zwerenz, Verena Leidgens, Giancarlo Feliciello, et al.
Cancers|December 10, 2021
Radiotherapy in Medulloblastoma-Evolution of Treatment, Current Concepts and Future PerspectivesClemens Seidel, Sina Heider, Peter Hau, et al.
Pageof 18

Showing results (11-20 of 180) with videos related to

Sort By:
Pageof 18
Expert Review of Neurotherapeutics|October 9, 2009
Advances in the therapy of high-grade glioma at relapse: pegylated liposomal doxorubicinPeter Hau, Joerg Dietrich, Klaus Fabel, et al.
Clinical Neuroradiology|June 24, 2016
The Neuroradiological Spectra of Adult and Pediatric Medulloblastoma Differ : Results from a Literature-based Meta-analysisDagmar Beier, Selin Kocakaya, Peter Hau, et al.
International Journal of Cancer|November 15, 2018
Reply to Lu: Connecting the dots between metformin and high-grade gliomaCorinna Seliger, Michael Gerken, Michael F Leitzmann, et al.
Acta Neuropathologica|May 22, 2013
Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approachMarkus J Riemenschneider, David N Louis, Michael Weller, et al.
Neurological Research and Practice|April 3, 2026
Preventive strategies against brain metastases: current state of the art and future directionsFranziska Maria Ippen, Franz Felix Konen, Peter Hau, et al.
Neuro-Oncology|December 29, 2014
Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patientsMarkus Hutterer, Elke Hattingen, Christoph Palm, et al.
Journal of Religion and Health|November 5, 2024
Spirituality in Professional Patient-Centered Care for Adults with Primary Brain Tumors: An Exploratory Scoping ReviewReinhard Grabenweger, Daniela Völz, Christiane Weck, et al.
Anticancer Research|May 17, 2002
Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal originPeter Hau, Rainer Apfel, Petra Wiese, et al.
International Journal of Molecular Sciences|March 18, 2020
Tumor Cell Invasion in GlioblastomaArabel Vollmann-Zwerenz, Verena Leidgens, Giancarlo Feliciello, et al.
Cancers|December 10, 2021
Radiotherapy in Medulloblastoma-Evolution of Treatment, Current Concepts and Future PerspectivesClemens Seidel, Sina Heider, Peter Hau, et al.
Pageof 18